Mentions
Extended reach
Total likes
Video views
AI synopsis
The overall discussions demonstrate strong support and high interest in the research's promising findings, with examples like calls for it to be a 'game-changer' and references to detection years and mutation levels, showing in-depth engagement and recognition of its potential to revolutionize cancer diagnosis and treatment.
Most discussions highlight the groundbreaking potential of early cancer detection, supporting the article's significance.
Posts show high enthusiasm and curiosity about the study and its implications, with several expressing optimism about future applications.
Participants reference specific details such as detection years and mutation levels, indicating a meaningful level of engagement.
Many discussions emphasize the transformative impact on early diagnosis and treatment, viewing the research as a major advancement in oncology.
Are we closer to blood-based screening tests for cancer? Report @CD_AACR leveraged plasma samples from the Atherosclerosis Risk in Communities study. Multicancer early detection (MCED) test was able to detect mutations up to 3.5y before diagnosis. https://t.co/GlX7klYoo9 https://t.co/9lW9qHB7Zl
Proof of principle study from Vogelstein et al @hopkinskimmel in @CD_AACR showing that in 4 of 6 patients with pre-diagnostic blood samples available 3-3.5 years prior to manifest cancer diagnosis, very low level mutations were detectable in the blood. https://t.co/Zhyd0efJn3 https://t.co/qHFEmBvvjM
The September issue of @CD_AACR is online and Bert Vogelstein's intriguing paper is on the cover Detection of Cancers Three Years prior to Diagnosis Using Plasma Cell-Free DNA https://t.co/quvY4f5S2U With an editorial by @Albert0Bardelli https://t.co/cevmgM9ADj https://t.co/pe37SXzOUI
Now online in @CD_AACR: Detection of Cancers Three Years Prior to Diagnosis Using Plasma Cell-Free DNA - by Yuxuan Wang, Nickolas Papadopoulos, Elizabeth Platz, Bert Vogelstein, and colleagues https://t.co/sSjxLgT0mi @hopkinskimmel https://t.co/soXCO6FWr1
Now online in Cancer Discovery: Detection of Cancers Three Years Prior to Diagnosis Using Plasma Cell-Free DNA - by Yuxuan Wang, Nickolas Papadopoulos, Elizabeth Platz, Bert Vogelstein, and colleagues doi.org/10.1158/2159...
Detection of Cancers Three Years Prior to Diagnosis Using Plasma Cell-Free DNA - Anirban Maitra @Aiims1742 @hopkinskimmel @CD_AACR https://t.co/yDlCIiqCgJ #OncoDaily #Oncology #Cancer #Health #Medicine #MedTwitter #MedEd #MedOnc #MedNews https://t.co/AC1Lxreayx
Researchers demonstrate the potential of blood-based circulating tumor DNA for early cancer detection, identifying mutations up to 3.5 years prior to clinical diagnosis, which may improve treatment outcomes and reduce…
Researchers used blood samples to detect cancer up to 3.5 years before diagnosis by identifying circulating tumor DNA, potentially enabling earlier treatment and reducing mortality.
Researchers have discovered a method to detect cancer three years before standard diagnosis by analyzing circulating tumor DNA in blood samples, potentially enabling earlier intervention and improving outcomes.
RT @CD_AACR: From the September issue: Detection of Cancers Three Years Prior to Diagnosis Using Plasma Cell-Free DNA https://t.co/SCht6cLS…
RT @SyedAAhmad5: Detection of Cancers Three Years prior to Diagnosis Using Plasma Cell-Free DNA @CD_AACR https://t.co/taGbzixFVp
Cancer Discovery: Detection of Cancers Three Years prior to Diagnosis Using Plasma Cell-Free DNA buff.ly/ugnsVZI
Detection of Cancers Three Years prior to Diagnosis Using Plasma Cell-Free DNA @CD_AACR https://t.co/taGbzixFVp
Read the September Editors' Pick: Detection of Cancers Three Years prior to Diagnosis Using Plasma Cell-Free DNA https://t.co/85g0T5NAqr https://t.co/jAC2ftSNjC
RT @VivekSubbiah: Detection of Cancers Three Years prior to Diagnosis Using Plasma Cell-Free DNA https://t.co/EMsqqqM0se
RT @SyedAAhmad5: Detection of Cancers Three Years prior to Diagnosis Using Plasma Cell-Free DNA @CD_AACR https://t.co/taGbzixFVp
RT @VivekSubbiah: Detection of Cancers Three Years prior to Diagnosis Using Plasma Cell-Free DNA https://t.co/EMsqqqM0se
RT @SyedAAhmad5: Detection of Cancers Three Years prior to Diagnosis Using Plasma Cell-Free DNA @CD_AACR https://t.co/taGbzixFVp
Detection of Cancers Three Years prior to Diagnosis Using Plasma Cell-Free DNA https://t.co/EMsqqqM0se
RT @SyedAAhmad5: Detection of Cancers Three Years prior to Diagnosis Using Plasma Cell-Free DNA @CD_AACR https://t.co/taGbzixFVp
RT @SyedAAhmad5: Detection of Cancers Three Years prior to Diagnosis Using Plasma Cell-Free DNA @CD_AACR https://t.co/taGbzixFVp
Detection of Cancers Three Years prior to Diagnosis Using Plasma Cell-Free DNA @CD_AACR https://t.co/taGbzixFVp
RT @CD_AACR: From the September issue: Detection of Cancers Three Years Prior to Diagnosis Using Plasma Cell-Free DNA https://t.co/SCht6cLS…
RT @CD_AACR: From the September issue: Detection of Cancers Three Years Prior to Diagnosis Using Plasma Cell-Free DNA https://t.co/SCht6cLS…
RT @CD_AACR: From the September issue: Detection of Cancers Three Years Prior to Diagnosis Using Plasma Cell-Free DNA https://t.co/SCht6cLS…
From the September issue: Detection of Cancers Three Years Prior to Diagnosis Using Plasma Cell-Free DNA https://t.co/SCht6cLSVI By Yuxuan Wang, Nickolas Papadopoulos, Elizabeth Platz, Bert Vogelstein, and colleagues @hopkinskimmel https://t.co/xLVWOxqLdH
RT @CD_AACR: Read the paper featured on the cover of this month’s Cancer Discovery: Detection of Cancers Three Years Prior to Diagnosis Usi…
RT @CD_AACR: Read the paper featured on the cover of this month’s Cancer Discovery: Detection of Cancers Three Years Prior to Diagnosis Usi…
RT @CD_AACR: Read the paper featured on the cover of this month’s Cancer Discovery: Detection of Cancers Three Years Prior to Diagnosis Usi…
Read the paper featured on the cover of this month’s Cancer Discovery: Detection of Cancers Three Years Prior to Diagnosis Using Plasma Cell-Free DNA - by Yuxuan Wang, Nickolas Papadopoulos, Elizabeth Platz, Bert Vogelstein, and colleagues https://t.co/SCht6cLSVI @hopkinskimmel https://t.co/XJQrqZEUEN
RT @Aiims1742: The September issue of @CD_AACR is online and Bert Vogelstein's intriguing paper is on the cover Detection of Cancers Three…
RT @Aiims1742: The September issue of @CD_AACR is online and Bert Vogelstein's intriguing paper is on the cover Detection of Cancers Three…
RT @Aiims1742: The September issue of @CD_AACR is online and Bert Vogelstein's intriguing paper is on the cover Detection of Cancers Three…
RT @Aiims1742: The September issue of @CD_AACR is online and Bert Vogelstein's intriguing paper is on the cover Detection of Cancers Three…
RT @Aiims1742: The September issue of @CD_AACR is online and Bert Vogelstein's intriguing paper is on the cover Detection of Cancers Three…
The September issue of @CD_AACR is online and Bert Vogelstein's intriguing paper is on the cover Detection of Cancers Three Years prior to Diagnosis Using Plasma Cell-Free DNA https://t.co/quvY4f5S2U With an editorial by @Albert0Bardelli https://t.co/cevmgM9ADj https://t.co/pe37SXzOUI
"Detection of Cancers Three Years prior to Diagnosis Using Plasma Cell-Free DNA" — Read it on @ResearchGate: https://t.co/6Vnfnm00c9
https://t.co/lgv0eAD42a
Groundbreaking study: Detection of Cancers Three Years prior to Diagnosis Using Plasma Cell-Free DNA https://t.co/6BZUNBm46Z
Detection of Cancers Three Years prior to Diagnosis Using Plasma Cell-Free DNA https://t.co/kYiJLwllqn
Another step toward earlier detection and treatment of cancer https://t.co/0ayGkhlMiv
Detection of Cancers Three Years prior to Diagnosis Using Plasma Cell-Free DNA | Cancer Discovery | American Association for Cancer Research https://t.co/gRhSgGkLEM
RT @CD_AACR: Read the recent article mentioned in The Washington Post, "Detection of Cancers Three Years prior to Diagnosis Using Plasma Ce…
RT @CD_AACR: Read the recent article mentioned in The Washington Post, "Detection of Cancers Three Years prior to Diagnosis Using Plasma Ce…
Read the recent article mentioned in The Washington Post, "Detection of Cancers Three Years prior to Diagnosis Using Plasma Cell-Free DNA:" https://t.co/mgcAgfNMqF https://t.co/lue3yYockQ
Detection of cancers three years prior to diagnosis using plasma cell-free DNA - PubMed https://t.co/qKVTlmVB5o
RT @feelgood2021: Des chercheurs de Johns Hopkins
RT @feelgood2021: Des chercheurs de Johns Hopkins
RT @feelgood2021: Des chercheurs de Johns Hopkins
RT @feelgood2021: Des chercheurs de Johns Hopkins
Des chercheurs de Johns Hopkins
RT @Abdullah_Med: رابط الدراسه: https://t.co/L4qYOdyGBx
رابط الدراسه: https://t.co/L4qYOdyGBx
がんは診断の何年も前に血液中で検出。診断の3年以上前に採取された血液サンプルに腫瘍の痕跡が見られる。 https://t.co/ESDWkuz01v https://t.co/vAhYOua0RE 潰瘍性大腸炎の発症は血液検査で数年前から予測可能。「睡眠不足」も発症リスクに。 https://t.co/r1AwUZcT2R https://t.co/qzmHHIriMk
Some really good work by John Hopkins University Researchers #Cancer #CancerAwareness https://t.co/SIaXHNFnSz
Recently published from @FoxNews: "A new study, published in the journal Cancer Discovery and partly funded by the @NIH, found that genetic material shed by tumors can be detected in the bloodstream three years prior to a cancer diagnosis." Read the study: https://t.co/ksarIJ64gl https://t.co/GcE3RqUSxE
Detection of cancers three years prior to diagnosis using plasma cell-free DNA | Cancer Discovery | American Association for Cancer Research https://t.co/m2aGR423RS
Sah dies und dachte an euch. Spannende Sache, die sich vielversprechend anhört. @DocOnco @DocGlitz @anna46977604 @vmuecke_k @dregenus @LiffersGert @DrHegedues https://t.co/AarD7e8lTv
Detection of cancers three years prior to diagnosis using plasma cell-free DNA https://t.co/sAO9yEMJbR
¡Noticia esperanzadora! Estudio revela que es posible detectar el cáncer hasta 3 años antes! Gracias a un análisis de sangre que halla material tumoral. Abre la puerta a tratamientos más tempranos. ¡Gran avance! #Cáncer #DetecciónPrecoz #Medicina https://t.co/PGdO9urwuZ
Nice "Detection of cancers three years prior to diagnosis using plasma cell-free DNA" https://t.co/nN6Zi4E9Qu
@FranzHefter @littlewisehen Doch, ganz am Ende: https://t.co/w6f42Y7snw
Detection of cancers three years prior to diagnosis using plasma cell-free DNA | Cancer Discovery | American Association for Cancer Research https://t.co/PpXjITP1u5
Detection of cancers three years prior to diagnosis using plasma cell-free DNA https://t.co/PlS57syjkI
Source: https://t.co/3qEJQTPVzS
Ref: Wang Y, Joshu CE, Curtis SD, et al. Detection of cancers three years prior to diagnosis using plasma cell-free DNA. Cancer Discov. 2025. doi: 10.1158/2159-8290.CD-25-0375 Molt bones notícies si hi ha voluntat!
Detection of cancers three years prior to diagnosis using plasma cell-free DNA https://t.co/Y92etXEqCQ
RT @Aiims1742: Proof of principle study from Vogelstein et al @hopkinskimmel in @CD_AACR showing that in 4 of 6 patients with pre-diagnosti…
RT @Aiims1742: Proof of principle study from Vogelstein et al @hopkinskimmel in @CD_AACR showing that in 4 of 6 patients with pre-diagnosti…
Detection of Cancers Three Years Prior to Diagnosis Using Plasma Cell-Free DNA - Anirban Maitra @Aiims1742 @hopkinskimmel @CD_AACR https://t.co/yDlCIiqCgJ #OncoDaily #Oncology #Cancer #Health #Medicine #MedTwitter #MedEd #MedOnc #MedNews https://t.co/AC1Lxreayx
RT @weldeiry: Detection of cancers three years prior to diagnosis using plasma cell-free DNA https://t.co/CIofQNnKEc
RT @Aiims1742: Proof of principle study from Vogelstein et al @hopkinskimmel in @CD_AACR showing that in 4 of 6 patients with pre-diagnosti…
RT @Aiims1742: Proof of principle study from Vogelstein et al @hopkinskimmel in @CD_AACR showing that in 4 of 6 patients with pre-diagnosti…
RT @Aiims1742: Proof of principle study from Vogelstein et al @hopkinskimmel in @CD_AACR showing that in 4 of 6 patients with pre-diagnosti…
RT @Aiims1742: Proof of principle study from Vogelstein et al @hopkinskimmel in @CD_AACR showing that in 4 of 6 patients with pre-diagnosti…
RT @Aiims1742: Proof of principle study from Vogelstein et al @hopkinskimmel in @CD_AACR showing that in 4 of 6 patients with pre-diagnosti…
Detection of cancers three years prior to diagnosis using plasma cell-free DNA aacrjournals.org/cancerdiscov...
Detection of cancers three years prior to diagnosis using plasma cell-free DNA https://t.co/CIofQNnKEc
Proof of principle study from Vogelstein et al @hopkinskimmel in @CD_AACR showing that in 4 of 6 patients with pre-diagnostic blood samples available 3-3.5 years prior to manifest cancer diagnosis, very low level mutations were detectable in the blood. https://t.co/Zhyd0efJn3 https://t.co/qHFEmBvvjM
RT @ElizSMcKenna: Now online in @CD_AACR: Detection of Cancers Three Years Prior to Diagnosis Using Plasma Cell-Free DNA - by Yuxuan Wang,…
RT @ElizSMcKenna: Now online in @CD_AACR: Detection of Cancers Three Years Prior to Diagnosis Using Plasma Cell-Free DNA - by Yuxuan Wang,…
RT @ElizSMcKenna: Now online in @CD_AACR: Detection of Cancers Three Years Prior to Diagnosis Using Plasma Cell-Free DNA - by Yuxuan Wang,…
RT @ElizSMcKenna: Now online in @CD_AACR: Detection of Cancers Three Years Prior to Diagnosis Using Plasma Cell-Free DNA - by Yuxuan Wang,…
RT @ElizSMcKenna: Now online in @CD_AACR: Detection of Cancers Three Years Prior to Diagnosis Using Plasma Cell-Free DNA - by Yuxuan Wang,…
RT @ElizSMcKenna: Now online in @CD_AACR: Detection of Cancers Three Years Prior to Diagnosis Using Plasma Cell-Free DNA - by Yuxuan Wang,…
Now online in Cancer Discovery: Detection of Cancers Three Years Prior to Diagnosis Using Plasma Cell-Free DNA - by Yuxuan Wang, Nickolas Papadopoulos, Elizabeth Platz, Bert Vogelstein, and colleagues doi.org/10.1158/2159...
Now online in @CD_AACR: Detection of Cancers Three Years Prior to Diagnosis Using Plasma Cell-Free DNA - by Yuxuan Wang, Nickolas Papadopoulos, Elizabeth Platz, Bert Vogelstein, and colleagues https://t.co/sSjxLgT0mi @hopkinskimmel https://t.co/soXCO6FWr1
RT @StephenVLiu: Are we closer to blood-based screening tests for cancer? Report @CD_AACR leveraged plasma samples from the Atherosclerosis…
RT @StephenVLiu: Are we closer to blood-based screening tests for cancer? Report @CD_AACR leveraged plasma samples from the Atherosclerosis…
RT @StephenVLiu: Are we closer to blood-based screening tests for cancer? Report @CD_AACR leveraged plasma samples from the Atherosclerosis…
RT @StephenVLiu: Are we closer to blood-based screening tests for cancer? Report @CD_AACR leveraged plasma samples from the Atherosclerosis…
RT @StephenVLiu: Are we closer to blood-based screening tests for cancer? Report @CD_AACR leveraged plasma samples from the Atherosclerosis…
Detection of cancers three years prior to diagnosis using plasma cell-free DNA https://t.co/32PQo3vz6y
RT @StephenVLiu: Are we closer to blood-based screening tests for cancer? Report @CD_AACR leveraged plasma samples from the Atherosclerosis…
RT @StephenVLiu: Are we closer to blood-based screening tests for cancer? Report @CD_AACR leveraged plasma samples from the Atherosclerosis…
RT @StephenVLiu: Are we closer to blood-based screening tests for cancer? Report @CD_AACR leveraged plasma samples from the Atherosclerosis…
RT @StephenVLiu: Are we closer to blood-based screening tests for cancer? Report @CD_AACR leveraged plasma samples from the Atherosclerosis…
RT @StephenVLiu: Are we closer to blood-based screening tests for cancer? Report @CD_AACR leveraged plasma samples from the Atherosclerosis…
RT @StephenVLiu: Are we closer to blood-based screening tests for cancer? Report @CD_AACR leveraged plasma samples from the Atherosclerosis…
RT @StephenVLiu: Are we closer to blood-based screening tests for cancer? Report @CD_AACR leveraged plasma samples from the Atherosclerosis…
RT @StephenVLiu: Are we closer to blood-based screening tests for cancer? Report @CD_AACR leveraged plasma samples from the Atherosclerosis…
Are we closer to blood-based screening tests for cancer? Report @CD_AACR leveraged plasma samples from the Atherosclerosis Risk in Communities study. Multicancer early detection (MCED) test was able to detect mutations up to 3.5y before diagnosis. https://t.co/GlX7klYoo9 https://t.co/9lW9qHB7Zl
#Cancer_Discov IF:29.7 Analysis of prospectively collected dataset. ctDNA was detected in 4 of 6 cancer cases more than three years before diagnosis, with mutant allele fractions ranging from 8.6- to 79-fold lower than at diagnosis. PMID:40402478 https://t.co/MPKV2Ox1AP
AM
JF
SA
CD